In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cedara Will Add Cardiology, Orthopedic Applications To eMed PACS Platform

This article was originally published in The Gray Sheet

Executive Summary

Cedara plans to increase sales of its medical software products by leveraging eMed Technologies' U.S. installed based of 450 PACS networks

Cedara plans to increase sales of its medical software products by leveraging eMed Technologies' U.S. installed based of 450 PACS networks.

Under a definitive merger agreement announced Sept. 14, Cedara will acquire eMed's picture archiving and communications systems (PACS) and web-based medical imaging radiology products for $48 mil. in cash.

Cedara estimates the purchase will help grow market share in imaging centers and small hospitals, which comprise eMed's base.

Cedara develops radiology software for device manufacturers and healthcare information technology providers such as GE Healthcare, Siemens, Philips, Toshiba, Hitachi and Cerner. Cedara estimates its software has been deployed in approximately 20,000 medical imaging systems and 4,600 PACS workstations worldwide.

Beyond radiology, Cedara is developing additional applications to complement eMed PACS systems, including those for orthopedics, cardiology, mammography using computer aided detection and virtual colonoscopy, according to eMed.

The firm also looks to benefit from Cedara's marketing and distribution networks in North America, Europe and Asia. eMed currently does not have an international presence.

The acquisition builds on a relationship between the firms dating to 1996, when Cedara first began using eMed's workstation. eMed recorded about $24 mil. in revenue during fiscal 2003 and has been consistently profitable over the last 24 months. Cedara had similar sales of $23.3 mil. last year and reported a loss of $10.3 mil.

eMed CEO Mark Smith will continue to lead the unit as a wholly-owned subsidiary of Cedara upon completion of the deal, expected by November. No material change to the structure of eMed will occur, according to Cedara.

The companies will have a combined 350 employees in the U.S. and Canada.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020894

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel